Innoviva (INVA) Selling, General & Administrative (2010 - 2026)
Innoviva (INVA) posted Selling, General & Administrative of $34.57 million for Q2 2026, up 30.9% from $26.41 million a year earlier and up 6.6% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Innoviva was $126.42 million, up 13.4% year-over-year; for FY2025, it came in at $113.32 million, down 2.1% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 52.2% (FY2020 to FY2025).
- In prior years, Innoviva's Selling, General & Administrative was $115.69 million in FY2024 (+17.8%), $98.23 million in FY2023 (+54.6%), $63.54 million in FY2022 (+292.5%) and $16.19 million in FY2021 (+16.6%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last four quarters, with growth averaging 6.9% over the last six quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2023, with growth of 204.0%; the weakest was Q4 2021, with a decline of 43.1%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $32.44 million (Q1 2026), $32.12 million (Q4 2025) and $27.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | 34.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.57 Mn |
| Mar 31, 2026 | 32.44 Mn |
| Dec 31, 2025 | 32.12 Mn |
| Sep 30, 2025 | 27.29 Mn |
| Jun 30, 2025 | 26.41 Mn |
| Mar 31, 2025 | 27.49 Mn |
| Dec 31, 2024 | 31.33 Mn |
| Sep 30, 2024 | 26.22 Mn |
| Jun 30, 2024 | 27.74 Mn |
| Mar 31, 2024 | 30.41 Mn |
| Sep 30, 2023 | 28.64 Mn |
| Jun 30, 2023 | 23.54 Mn |
| Mar 31, 2023 | 19.74 Mn |
| Sep 30, 2022 | 27.81 Mn |
| Jun 30, 2022 | 11.78 Mn |
| Mar 31, 2022 | 6.49 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 2.86 Mn |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 5.99 Mn |
API Access
Innoviva Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();